Phân tích Δ9-tetrahydrocannabinol và các chất chuyển hóa của nó trong huyết tương người bằng phương pháp sắc ký lỏng - phổ khối tách tầng dựa trên việc kết tủa protein đơn giản

Baselt RC (2011) Disposition of toxic drugs and chemicals in man. Biomedical Publications, Seal Beach Dziadosz M, Weller JP, Klintschar M, Teske J (2013) Scheduled multiple reaction monitoring algorithm as a way to analyse new designer drugs combined with synthetic cannabinoids in human serum with liquid chromatography–tandem mass spectrometry. J Chromatogr B 929:84–89 Dziadosz M, Klintschar M, Teske J (2014) Mixed consumption of cannabis and “Spice”. Forensic Sci Int 235:e1–e2 Gustafson RA, Moolchan ET, Barnes A, Levine B, Huestis MA (2003) Validated method for the simultaneous determination of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC and 11-nor-9-carboxy-THC in human plasma using solid phase extraction and gas chromatography–mass spectrometry with positive chemical ionization. J Chromatogr B 798:145–154 Hidvégi E, Somogyi GP (2014) Determination of main tetrahydrocannabinoids by GC–MS: impact of protein precipitation by acetonitrile on solid phase extraction of cannabinoids from human serum. Pharmazie 69:417–419 Lowe RH, Karschner EL, Schwilke EW, Barnes AJ, Huestis MA (2007) Simultaneous quantification of Δ9-tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol, and 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid in human plasma using two-dimensional gas chromatography, cryofocusing, and electron impact-mass spectrometry. J Chromatogr A 1163:318–327 Nadulski T, Sporkert F, Schnelle M, Stadelmann AM, Roser P, Schefter T, Pragst F (2005) Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC–MS in plasma after oral application of small doses of THC and cannabis extract. J Anal Toxicol 29:782–789 Purschke K, Heinl S, Lerch O, Erdmann F, Veit F (2016) Development and validation of an automated liquid-liquid extraction GC/MS method for the determination of THC, 11-OH-THC, and free THC-carboxylic acid (THC-COOH) from blood serum. Anal Bioanal Chem 408:4379–4388 Röhrich J, Schimmel I, Zörntlein S, Becker J, Drobnik S, Kaufmann T, Kuntz V, Urban R (2010) Concentrations of Δ9-tetrahydrocannabinol and 11-nor-9-carboxytetrahydrocannabinol in blood and urine after passive exposure to cannabis smoke in a coffee shop. J Anal Toxicol 34:196–203 Scurlock RD, Ohlson GB, Worthen DK (2006) The detection of Δ9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol (THCA) in whole blood using two-dimensional gas chromatography and EI-mass spectrometry. J Anal Toxicol 30:262–266 Steinmeyer S, Bregel D, Warth S, Kraemer T, Moeller MR (2002) Improved and validated method for the determination of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC and 11-nor-9-carboxy-THC in serum, and in human liver microsomal preparations using gas chromatography–mass spectrometry. J Chromatogr B 772:239–248 Thomas A, Widmer C, Hopfgartner G, Staub C (2007) Fast gas chromatography and negative-ion chemical ionization tandem mass spectrometry for forensic analysis of cannabinoids in whole blood. J Pharm Biomed Anal 45:495–503 Weller JP, Wolf M, Szidat S (2000) Enhanced selectivity in the determination of Δ9-tetrahydrocannabinol and two major metabolites in serum using ion-trap GC–MS-MS. J Anal Toxicol 24:359–364 Coulter C, Miller E, Crompton K, Moore C (2008) Tetrahydrocannabinol and two of its metabolites in whole blood using liquid chromatography–tandem mass spectrometry. J Anal Toxicol 32:653–658 Dubois N, Paccou AP, De Backer BG, Charlier CJ (2012) Validation of the quantitative determination of tetrahydrocannabinol and its two major metabolites in plasma by ultra-high-performance liquid chromatography–tandem mass spectrometry according to the total error approach. J Anal Toxicol 36:25–29 Elian AA, Hackett J (2009) Solid-phase extraction and analysis of THC and carboxy-THC from whole blood using a novel fluorinated solid phase extraction sorbent and fast liquid chromatography–tandem mass spectrometry. J Anal Toxicol 33:461–468 Del Mar Ramirez Fernandez M, De Boeck G, Wood M, Lopez-Rivadulla M, Samyn N (2008) Simultaneous analysis of THC and its metabolites in blood using liquid chromatography–tandem mass spectrometry. J Chromatogr B 875:465–470 Jagerdeo E, Schaff JE, Montgomery MA, LeBeau MA (2009) A semi-automated solid-phase extraction liquid chromatography/tandem mass spectrometry method for the analysis of tetrahydrocannabinol and metabolites in whole blood. Rapid Commun Mass Spectrom 23:2697–2705 Jamey C, Szwarc E, Tracqui A, Ludes B (2008) Determination of cannabinoids in whole blood by UPLC–MS–MS. J Anal Toxicol 32:349–354 König S, Aebi B, Lanz S, Gasser M, Weinmann W (2011) On-line SPE LC–MS/MS for the quantification of Δ9-tetrahydrocannabinol (THC) and its two major metabolites in human peripheral blood by liquid chromatography tandem mass spectrometry. Anal Bioanal Chem 400:9–16 Laloup M, Del Mar Ramirez Fernandez M, Wood M, De Boeck G, Maes V, Samyn N (2006) Correlation of Δ9-tetrahydrocannabinol concentrations determined by LC–MS–MS in oral fluid and plasma from impaired drivers and evaluation of the on-site Dräger DrugTest®. Forensic Sci Int 161:175–179 Moralikova B, Weinmann W (2004) Simultaneous determination of Δ9-tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in human plasma by high-performance liquid chromatography/tandem mass spectrometry. J Mass Spectrom 39:526–531 Schwope DM, Scheidweiler KB, Huestis MA (2011) Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography–tandem mass spectrometry. Anal Bioanal Chem 401:1273–1283 Peters FT, Hartung M, Herbold M, Schmitt G, Daldrup T, Mußhoff F (2009) Anhang B zur Richtlinie der GTFCh zur Qualitätssicherung bei forensisch-toxikologischen Untersuchungen. Anforderungen an die Validierung von Analysenmethoden. Toxichem Krimtech 76:185–208 Matuszewski BK, Constanzer ML, Chavez-Eng CM (2003) Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC–MS/MS. Anal Chem 75:3019–3030 Skopp G, Pötsch L, Mauden M, Richter B (2002) Partition coefficient, blood to plasma ratio, protein binding and short-term stability of 11-nor-Δ9-carboxy tetrahydrocannabinol glucuronide. Forensic Sci Int 126:17–23 Skopp G, Pötsch L (2002) Stability of 11-nor-Δ9-carboxy-tetrahydrocannabinol glucuronide in plasma and urine assessed by liquid chromatography–tandem mass spectrometry. Clin Chem 48:301–306 Schwope DM, Karschner EL, Gorelick DA, Huestis MA (2011) Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration. Clin Chem 57:1406–1414